• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Palatin Technologies (NY: PTN )

    1.170 -0.020 (-1.68%)
    Official Closing Price Updated: 8:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Palatin Technologies

    < Previous 1 2 3 4 Next >
    10 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions
    Palatin Technologies: Utilizing The Melanocortin System As The Basis For Innovation In Drug Development – Targeting Inflammatory & Autoimmune Conditions, Obesity And Sexual Dysfunctions 
    Via News Direct
    Exposures Product Safety
    Earnings Scheduled For February 15, 2024
    Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
    Via Benzinga
    Earnings Preview: Palatin Techs
    Via Benzinga
    Recap: Palatin Techs Q1 Earnings
    Via Benzinga
    Palatin Techs's Earnings Outlook
    Via Benzinga
    PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
    PTN stock results show that Palatin Techs missed analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
    The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data
    Palatin Technologies unveils Phase 3 PL9643 MELODY-1 trial results for dry eye disease treatment, showcasing statistically significant efficacy in pain reduction and secondary symptoms. PL9643... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets
    Palatin Technologies' results from PL9643 MELODY-1 Phase 3 trial for dry eye disease. The co-primary endpoints and secondary endpoints did not reach statistical significance. 
    Via Benzinga
    Earnings Outlook For Palatin Techs
    Via Benzinga
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. 
    Via Benzinga
    Dow Dips 200 Points; TJX Posts Upbeat Sales
    U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    The 3 Best Penny Stocks to Buy in February 2024
    With proposed FED rate cuts incoming, these are the penny stocks that are likely to see a spark into new rallies. 
    Via InvestorPlace
    7 Analyst-Backed Stocks With Promising 10-Bagger Potential
    Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot. 
    Via InvestorPlace
    3 Penny Stocks to Buy to Unlock 2,500% Upside Potential
    These penny stocks have triple-digit upside as 2024 brings easing monetary policy and economic normalization. 
    Via InvestorPlace
    Cosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.
    From Cosette Pharmaceuticals, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Analysts Say 3 Stocks Have a Combined Upside of 3000%
    These high-risk, high-reward bets could be at an inflection point before their growth takes off next year. 
    Via InvestorPlace
    Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
    Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today! 
    Via InvestorPlace
    Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders
    EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Earnings Scheduled For September 28, 2023
    Companies Reporting Before The Bell • CarMax (NYSE:KMX) is projected to report quarterly earnings at $0.78 per share on revenue of $7.03 billion. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      During Tuesday's session, 275 companies made new 52-week lows. 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.